The historic rise of Viagra has long been a benchmark of pharmaceutical success, but its future within the broader industry now presents questions about long-term yields . Copycat versions are undercutting https://onelifesocial.com/story6928295/copyright-s-pill-and-pharma-a-precarious-opportunity